including ALS, such changes may be a risk factor for pathogenesis.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disorder characterized by the loss of motor neurons (Cleveland and Rothstein, 2001; Bruijn et al., 2004) . Approximately 10% of ALS cases are familial, and approximately 20% of these cases are caused by mutations in the gene encoding SOD1 (Rosen et al., 1993) . The majority of ALS-linked mutations of SOD1 lead to folding instability and misfolding, with aggregates of mutant SOD1 detected in the spinal cord of affected individuals (Bruijn et al., 1998) . Accumulation of mutant SOD1 aggregates has been proposed to lead to neuronal cell death by gain-of-function toxicity and inhibition of a multitude of cellular functions including axonal transport, mitochondrial function, and protein homeostasis (Williamson et al., 2000; Bruijn et al., 2004; Matsumoto et al., 2005; Gidalevitz et al., 2009) . Similarly, sporadic ALS is associated with mutations and aggregation of TDP-43 and FUS (Da Cruz and Cleveland, 2011) .
Although the molecular mechanisms underlying the cytotoxicity of mutant SOD1, TDP-43, and FUS are poorly understood, it is possible that misfolding and aggregation interfere with many cellular processes, either directly by co-sequestration (Olzscha et al., 2011) or by chaperone competition and proteostatic collapse (Gidalevitz et al., 2006; Gidalevitz et al., 2010) .
The balance of folding and misfolding is regulated by proteostatic pathways, which include chaperone network as well as the clearance machineries of the proteasome and autophagy (Holmberg et al., 2004; Vabulas and Hartl 2005; Vilchez et al., 2012) . Genetic screens and proteomics have identified key components involved in proteostasis, as well as the networks that are affected by protein conformational disease or can alter the course of such diseases (Holmberg et al., 2004; Vilchez et al., 2012) . Expression of misfolded and aggregation-prone proteins has multiple consequences, including direct effects, such as inhibition of proteasome activity, and indirect effects, such as interference with the degradation of other proteins. Mutant SOD1 is polyubiquitinated and degraded by the ubiquitin-proteasome system (Johnston et al., 2000; Niwa et al., 2007) . Consequently, inhibition of proteasome activity increases the accumulation of mutant but not wild-type SOD1 into aggregates (Johnston et al., 2000; Niwa et al., 2007) . Mutant SOD1 aggregates to form amorphous structures comprised of mobile components that can exchange with soluble mutant SOD1 in the cytosol (Matsumoto et al., 2005) . However, little is known about the properties of the aggregated and soluble states of mutant SOD1 or their relevance to toxicity. Here, we show that the toxicity of mutant SOD1 aggregates expressed in cultured human cells is determined by the state and activity of the proteasome.
Using spectroscopic approaches with single-molecule sensitivity, we demonstrated the persistence of soluble and ordered oligomeric species of SOD1 mutants during the inhibition of proteasome activity.
Furthermore, we found that marked cellular toxicity was only observed during recovery from proteasome inhibition.
RESULTS

Dissociation of mutant SOD1 from aggresomes during recovery of proteasome activity --We examined
the aggregation and toxicity of mutant SOD1 expressed in a HeLa cell line engineered for conditional expression of tagged wild-type SOD1 (SOD1-wt-YFP) or an ALS-linked SOD1 mutant with a G85R mutation (SOD1-G85R-YFP), using a tetracycline-regulated promoter under the control of doxycycline.
After 16 hours treatment with the proteasome inhibitor MG-132 (2 µM), SOD1-G85R-YFP formed perinuclear inclusions in ~96% of cells, whereas SOD1-wt-YFP was unaffected (Fig. 1, A and B) . The accumulation of aggregated mutant SOD1 in MG-132-treated cells was confirmed by centrifugal fractionation (Fig. S1A) , the filter-trap assay (Fig. S1B) , and immunostaining analysis (Fig. S1D ) using antibodies against aggresome markers (Johnston et al., 2000; Kopito 2000) .
We next examined the fate of mutant SOD1 inclusions during recovery of proteasome activity.
MG-132-treated cells expressing mutant SOD1 were transferred to recovery medium lacking MG-132, and proteasome activity was measured using a proteasome-targeted GFP substrate (GFPu) (Bence et al., 2001) . After incubation in MG-132-free medium, proteasome activity was recovered within 4 hours ( Fig.   S2 ). Time-lapse observations of individual cells revealed that SOD1-G85R-YFP inclusions were no longer detectable after 20 hours of recovery (Fig. 1C) ; inclusions had a half-life of ~9 hours (Fig. 1D) .
No significant morphological changes of the cells were observed during these processes. Likewise, the detergent-insoluble fraction of SOD1-G85R-YFP aggregates decreased by 50% during recovery (Fig. S1, A and C). Similar results were observed in cells treated with the specific proteasome inhibitor epoxomicin, although the half-life of inclusions was slightly extended relative to cells treated with MG-132 (Fig. S1E) . The decrease in mutant SOD1 inclusions was also observed in MG-132-treated cells allowed to recover in the presence of an autophagy/lysosome inhibitor, bafilomycin A1 (0.1 µM) (Fig.   S1F ). LC3 accumulation, a standard indicator of autophagosome formation, was clearly observed following treatment with bafilomycin A1 at the same concentration (Fig. S1F inset) , suggesting that autophagy is not essential for disaggregation. These results indicate that living cells possess a mechanism for disaggregation of proteins that is associated with the restoration of proteasome activity.
To examine whether mutant SOD1 that dissociates from inclusions redistributes into the soluble state in the cytoplasm, we performed dynamic imaging experiments using a monomeric variant of photoactivatable green fluorescent protein (mPAGFP). This variant can be converted from a dark state to a bright green fluorescent state by irradiation with violet light (Patterson and Lippincott-Schwartz, 2002; Lippincott-Schwartz et al., 2001) . In cells expressing SOD1-G85R-mPAGFP, ROIs in the inclusion or cytosol were converted to the bright state by 0.45-s irradiation with violet light. In control cells, fluorescence intensity of photoactivated inclusions decreased rapidly, reaching 50% after 3 hours of recovery in the absence of MG-132, and the aggresome structures containing photoactivated SOD1 gradually expanded ( Fig. 2A) . By contrast, in the presence of MG-132, fluorescence intensity decreased by only 25% during the same period, and the shapes of aggresome structures were unchanged ( Fig. 2A) .
Photoactivation of cytosolic SOD1-G85R-mPAGFP also revealed a faster decrease in fluorescence intensity under recovery conditions than in the presence of MG-132 (Fig. 2B) , suggesting that mutant SOD1 is degraded in the cytosol. These results suggest that mutant SOD1 dissociates from inclusions and enters the cytosol, where it is degraded.
Formation and disappearance of soluble oligomers of mutant SOD1, depending on proteasome activity
--We next determined the oligomeric state of the soluble mutant SOD1 that appears upon elevation of proteasome activity. To this end, we used FCS, a method developed to analyze rapid movements of fluorescent molecules at single-molecule sensitivity (Rigler et al., 1993; Lippincott-Schwartz et al., 2001; Kitamura et al., 2006) . Cells expressing SOD1-YFP were lysed, and the soluble fraction was recovered and analyzed by FCS. The size of SOD1-wt-YFP, calculated from the diffusion time, indicated the presence of a dimeric species (~79 kDa, Fig. 3A, lanes 3-7) . By contrast, in the absence of MG-132, mutant SOD1-G85R-YFP exhibited a diffusion time intermediate between those of monomers and dimers (~60 kDa, Fig. 3A , lane 8), suggesting that both monomers and dimers were present under these conditions, as previously reported (Johnston et al., 2000; Wang et al., 2009) . In the presence of MG-132 treatment, FCS revealed the presence of high molecular weight species (~1000 kDa) of mutant SOD1 (Fig. 3A, lane 10 to 12 ). These high molecular weight species were significantly smaller than previously reported soluble aggregates of expanded polyglutamine (>100 MDa) (Kitamura et al., 2006) .
We also confirmed the formation of high molecular weight species of SOD1-G85R-YFP during inhibition of proteasome activity by sucrose density-gradient ultracentrifugation analysis (Fig. S5) .
Further, we also observed the accumulation of poly-ubiquitinated SOD1-G85R-YFP during the inhibition of proteasome activity (Fig. S6) . In FCS analysis, count per molecule (CPM), a mean brightness of the particles, is a useful indicator of the formation of high molecular weight species such as oligomer formation. CPM ratio of SOD1-G85R-YFP was significantly increased during inhibition of proteasome activity compared with SOD1-WT-YFP and YFP monomer (Fig. 3B) . Thus, we concluded that the high molecular weight species of SOD1-G85R-YFP detected by CPM ratio are composed of soluble oligomers. In contrast, following transfer to recovery medium, the SOD1-G85R-YFP oligomers disappeared over a period of 6 hours (Fig. 3C, lanes 1 to 3) . The size of SOD1-G85R-YFP oligomers decreased following treatment with 100 mM dithiothreitol, a strong reducing agent (Fig. S4A , lanes 12 to 16; and Fig. S4B , lanes 7 to 12), in agreement with the observation that mutant SOD1 can form disulfide bond-dependent aggregates (Niwa et al., 2007; Furukawa et al., 2008; Karch and Borchelt, 2008) .
We quantitatively determined the diffusion coefficients of SOD1-mGFPs in live cells using two-component curve fitting analysis of the autocorrelation function measured by FCS ( Fig. 4A and Table 1 ). The fast diffusion coefficient of SOD1-G85R-mGFP in the presence of MG-132 (16.9 ± 3.8 µm 2 /s) was significantly smaller than that of G85R in the absence of MG-132 (Table 1) and that of the WT protein in the presence or absence of MG-132 (Table 1) . SOD1-G85R-mGFP had the smallest slow diffusion coefficient (0.52 ± 0.40 µm 2 /s) ( Table 1 ). The ratios of fast-diffusing to slowly diffusing molecules exhibited no significant differences (Table 1) . These data clearly showed that the diffusion rate of SOD1-G85R-mGFP in the presence of MG-132 was slower than that of the G85R mutant in the absence of MG-132, and that of the wild-type protein under either condition. In general, diffusion rate in the cytoplasm decreases as molecular weight increases (see also the Stokes-Einstein relation described in Experimental procedure). In addition, CPM ratio of SOD1-G85R-YFP was increased compared with SOD1-WT-YFP (Fig. 4B) . Therefore, the slow diffusion of SOD1-G85R-mGFP in presence of MG-132 is a consequence of oligomerization. As these findings are in agreement with previously reported diffusion coefficients obtained by FRAP analysis (Matsumoto et al., 2005) , it is clear that FCS can detect the oligomeric state of mutant SOD1.
Dynamic conformational transition of aggregated mutant SOD1 -We next examined the structural basis of the mutant SOD1 oligomers using intermolecular Förster resonance energy transfer (FRET), which detects molecular interactions (including distance and orientation) between fluorophores (Lippincott-Schwartz et al., 2001) . For quantitative FRET analysis, we employed fluorescence lifetime imaging microscopy (FLIM) (Yasuda, 2006) , in which the fluorescence lifetime of a donor fluorophore (τ d ) becomes shorter in response to energy transfer. We chose mTFP1 as a donor, because it is a bright monomeric cyan fluorescent protein with a single component fluorescence lifetime (Ai et al., 2006) , and conventional mVenus, a bright monomeric yellow protein, as the acceptor. As previously reported, when both donor and acceptor fluorescent proteins were tagged with SOD1-G85R, no significant FRET was observed, even in the presence of MG-132 ( Fig. S7A) . We hypothesized that the absence of FRET could be due to an inappropriate orientation between the two fluorophores. Therefore, we constructed several circularly permutated mVenus proteins, which exhibit altered rotational orientations between the fluorophores (Nagai et al., 2004) , and tested these as acceptors.
Among them, one of the mVenus variants, cp173mVenus, exhibited significant FRET (τ d = 1.8 ± 0.23 ns) in inclusions ( Fig. 5A, c (Fig. 7) .
DISCUSSION
Here, we have shown that the formation of mutant SOD1 aggregates and the toxicity of the mutant protein can be regulated by the modulation of proteasome activity. The appearance of aggregate species and cellular toxicity appear to be inversely related: under normal conditions of expression, mutant SOD1 is highly aggregation-prone but exhibits very little toxicity. However, when the activity of the proteasome is transiently inhibited, only upon recovery do we observe the appearance of ordered soluble oligomers and associated cellular toxicity.
Over the past years, multiple types of cellular inclusions have been identified in various prokaryotic and eukaryotic organisms, and the biological relevance of inclusion formation has been debated. A recent study reported that misfolded cytosolic proteins are partitioned into either a 'juxta nuclear quality control compartment (JUNQ)' or an 'insoluble protein deposit (IPOD)' (Kaganovich et al., 2008) . Bagola and Sommer pointed out that the classical aggresome structure shares features in common with JUNQ: both are formed under stress, such as inhibition of the proteasome, although they are distinguished by the presence or absence of a vimentin cage (Bagola & Sommer 2008) . The data presented here indicate that following proteasome inhibition, mutant SOD1 is sequestered into inclusions, which correspond to a subcellular compartment for quality control, like JUNQ. We have also clearly shown that during recovery of proteasomal activity, mutant SOD1 can be dissociated from inclusions as soluble oligomers (Figs. 1-4). These findings suggest the existence of a cytosolic quality control system for misfolded SOD1, which includes disaggregation from a quality control compartment and the degradation of released misfolded proteins. Moreover, FRET-FLIM analysis revealed that the intermolecular orientation of mutant SOD1 in inclusions can be rearranged during disaggregation ( (Winkler et al., 2012) ; likewise, several molecular chaperones may be orchestrated and involved in the disaggregation process of mutant SOD1. Therefore, it will be important to elucidate not only the mechanism by which misfolded proteins are sorted into specific compartment, but also the details of the dissociation process.
With respect to the relationship between cytotoxicity and aggregate formation, it has been controversial whether and how aggregation of misfolded protein leads to cellular toxicity. For example, the formation of inclusions containing mutant huntingtin has been hypothesized to improve survival and reduce the level of toxicity in neuronal cells (Arrasate et al., 2004) , whereas aggregates of mutant SOD1 are correlated directly with neuronal cell death (Matsumoto et al., 2005) . Here, we showed that the cellular toxicity of mutant SOD1 is exerted when proteasomal activity recovers upon removal of a proteasome inhibitor (Fig. 6 ). There is a likely explanation for these unexpected observations. When mutant SOD1 is misfolded, the toxic region of mutant SOD1 is sequestered through oligomerization; however, during the recovery of proteasome activity, the dissociation of inclusions could expose a toxic interface of oligomers (Fig. 7) . Although the average size of mutant SOD1 oligomers and the intermolecular distance of mutant SOD1 within oligomers are equal during inhibition and recovery of proteasome activity ( Fig. 3 and 5) , the intermolecular orientations of mutant SOD1 in inclusions could be dynamically exchanged between these two states ( Fig. 2A; Fig. 5B , lanes 5 and 8; Fig. 5C , lane 4).
Furthermore, mutation-dependent structural polymorphism of SOD1 aggregates has been suggested (Furukawa et al., 2010) . We therefore hypothesize that the structure of mutant SOD1 aggregates fluctuates and the dynamic exchange in inclusions may cause the production of diverse structure of oligomers. In familial ALS, cell death of motor neurons appears to result from a gain-of-function toxic phenotype of SOD1 (Brujin et al., 1998; Furukawa et al., 2006; Bosco et al., 2010) . Also, many reports demonstrate the relationship between conformational change of SOD1 and cytotoxicity (Lilley and Ploegh 2005; Oda et al., 2006; Nishitoh et al., 2008; VandeVelde et al., 2008; Ilieva et al., 2009; Fujisawa et al., 2012) . For example, conformation-dependent binding of mutant SOD1 to Derlin-1 (Lilley and Ploegh 2005; Oda et al., 2006) inhibits endoplasmic reticulum (ER)-associated degradation (ERAD) and thereby generates ER stress (Nishitoh et al., 2008; Ilieva et al., 2009; Fujisawa et al., 2012) . Mutant SOD1 is thought to damage mitochondria by being deposited on the cytoplasmic surface of the outer membrane (VandeVelde et al., 2008) . Thus, the toxic region(s) of mutant SOD1 oligomers are likely to interact with and inactivate a number of endogenous functional proteins.
Moreover, mutant SOD1 interacts with Hsc70 in the mouse spinal cord during early development, and Hsp110 associates with soluble oligomers of mutant SOD1 during aging, when mutant SOD1 exerts neurotoxicity (Wang et al., 2009) . Several groups, including ours, report that the cytosolic chaperonin CCT/TRiC, which inhibits the aggregation of hydrophobic β-sheet-containing proteins Hartl and Hayer-Hartl 2009 ), reduces polyglutamine toxicity by altering the state of soluble aggregates (Behrends et al., 2006; Kitamura et al., 2006; Tam et al., 2006) . CCT/TRiC may inhibit the toxicity of mutant SOD1 during modulation of proteasome activity in the same way. Alternatively, the molecular characteristics of the diverse oligomeric species liberated from mutant SOD1 inclusions may differ with respect to their structures and modifications. Post-translational modifications of mutant SOD1 have been implicated in the transition from monomeric to aggregated states (Fujiwara et al., 2007; Furukawa et al., 2008) ; consequently, such modifications could also affect the soluble oligomeric structures, which closely correlate with cytotoxicity (Holmberg et al., 2004) . For example, in sporadic ALS, aggregation of an over-oxidized form of SOD1 damages mitochondria in lymphoblasts (Guareschi et al., 2012) . Indeed, oxidization of mutant SOD1 also causes toxicity in motor neurons (Kabashi et al., 2007) . These reports imply that post-translational modifications of SOD1 can influence both conformational changes and toxicity.
Thus, we have established that the modulation of proteasome activity induces a conformational change of oligomeric misfolded SOD1, which is closely related to cellular toxicity. Our findings suggest that fluctuation of proteasome activity during aging and/or under transient stress may cause the emergence of toxic species and be a risk factor for neuronal cell death in neurodegenerative disorders.
Further detailed analyses of the mechanism by which the modulation of proteasome activity changes conformations of mutant SOD1 in cells will enhance our understanding of neuronal cell death and pathophysiology. Such understanding will assist in the design of therapeutic strategies for ALS caused by SOD1 carrying aggregate-prone mutations, and perhaps for other neurodegenerative diseases.
Experimental procedures
Construction of plasmids --Plasmids for producing stable tet-off cell lines that express YFP-tagged wild-type (pTRE-SOD1-wt-YFP) and mutant SOD1 (pTRE-SOD1-G85R-YFP) under the control of doxycycline were described previously (Matsumoto et al., 2005 et al., 2002) , cp173mVenus (a circularly permutated mVenus, which exhibits altered rotational orientations between the fluorophores; kindly provided by Dr. Takeharu Nagai, Osaka University, Japan) (Nagai et al., 2004) and TagRFP (a monomeric red fluorescent protein; Evrogen, Moscow, Russia) (Merzlyak et al., 2007) , yielding the expression vectors pTRE-SOD1-wt-mGFP, pTRE-SOD1-G85R-mGFP, pTRE-SOD1-G85R-mPAGFP, pTRE-SOD1-wt-mTFP1, pTRE-SOD1-G85R-mTFP1, pTRE-SOD1-wt-cp173mVenus, pTRE-SOD1-G85R-cp173mVenus, pTRE-SOD1-wt-mVenus, pTRE-SOD1-G85R-mVenus, pTRE-SOD1-wt-TagRFP and pTRE-SOD1-G85R-TagRFP, respectively. To avoid translational initiation from an internal ATG codon within the SOD1-fluorescent protein fusions, all methionines (ATG) in the N-terminal regions of the fluorescent proteins were converted to alanines (GCC) using a one-primer quick-change method (Miyawaki et al., 2003) or PCR amplification. For proteasome activity measurements, a proteasomal degron CL1 tag (ACKNWFSSLSHFVIHL) (Bence et al., 2001 ) was inserted at the carboxyl terminus of EGFP (pEGFP-C1; CLONTECH) to yield the constitutively degraded variant GFPu.
Cell culture and establishment of stable cell lines --HeLa tet-off cell lines (Clontech), in which expression from pTRE vectors is regulated by doxycycline, were cultured in Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich, St. Louis, MO) supplemented with 10% fetal bovine serum (FBS; J R Scientific, Woodland, CA), 200 µg/ml G418 (Nacalai Tesque, Kyoto, Japan), 100 units/ml penicillin G (Sigma-Aldrich), and 100 µg/ml streptomycin (Sigma-Aldrich) in a humidified 5% CO 2 /95% air atmosphere at 37°C. HeLa tet-off cell lines for doxycycline-regulated expression of YFP, SOD1-wt-YFP, or SOD1-G85R-YFP were selected in medium supplemented with 500 µg/ml HygroGold (Invivogen, San Diego, CA) and 1.0 µg/ml doxycycline (Sigma-Aldrich). For transfections, cells were seeded on 3.5-cm dishes (BD, Franklin Lakes, NJ) or 3.5-cm glass-based dishes (Asahi-Technoglass, Tokyo, Japan) 1 day before transfection. All constructs were transfected using Effectene (Qiagen, Düsseldorf, Germany). For photoactivation analysis, mixtures of pTRE-SOD1-G85R-mPAGFP and pTRE-SOD1-G85R-TagRFP constructs (1:1) were transfected into HeLa tet-off cells. For FRET-FLIM assays, pTRE-SOD1-G85R-cp173mVenus or the control were washed in HBSS (Sigma-Aldrich) and cultured for up to 16 hours in medium lacking doxycycline and supplemented with 2 µM MG-132 (Peptide Institute, Osaka, Japan) to inhibit proteasome activity.
As a negative control for proteasome inhibition, 0.02% DMSO (Nacalai Tesque) was added instead of MG-132. Cells were then washed three times in HBSS and cultured in medium lacking MG-132, to recover proteasome activity, but supplemented with 1.0 µg/ml doxycycline, to inhibit transcription of SOD1 genes. Treatment with 50 nM epoxomicin (Sigma-Aldrich) was performed in the same manner as treatment with MG-132. Inhibition of autophagy and lysosomal protein degradation was performed in medium supplemented with 0.1 µM bafilomycin A1 (Sigma-Aldrich) after 16-h treatment in medium supplemented with 2 µM MG-132.
Immunofluorescence analysis --Cells were cultivated on acid-washed and type I collagen-coated coverslips (0.14-0.18 mm) (Matsumami Glass Ind., Ltd., Osaka, Japan), and then fixed with 4% paraformaldehyde at 37°C (for staining for ubiquitin, Hsp70, Hsc70, vimentin, and the 20S proteasome) or in ice-cold methanol at -20 °C (for α-tubulin staining). Cells were washed in TBS and permeabilized in the presence of 0.5% (v/v) Triton X-100 (Sigma-Aldrich) and 0.5% (w/v) saponin (Nacalai Tesque).
After blocking non-specific binding activity in blocking buffer containing 5% normal goat serum Filter-trap assay --Cells expressing SOD1-YFPs were suspended in PBS containing 1%
protease-inhibitor cocktail and lysed by freeze-thawing. After determination of protein concentrations, cell lysates (300 µg protein) were diluted in PBS containing 1% SDS and sonicated. Samples were loaded onto a cellulose-acetate membrane (0.2-µm pore size; Advantec Toyo, Ltd., Tokyo, Japan) on a Bio-Dot SF vacuum blotter (Bio-Rad Laboratories, Hercules, CA). Trapped SOD1-YFP aggregates were detected by western blotting using anti-GFP antibody.
Photoactivation analysis in living cells --Cells expressing both SOD1-G85R-mPAGFP and
SOD1-G85R-TagRFP were cultured in a glass-based dish with printed grid patterns. Cells were observed on a LSM 510 META microscope using a C-Apochromat 40×/1.2NA UV-VIS-IR DIC water-immersion objective. After a region of interest (ROI) was determined using the red channel, mPAGFPs in the ROI were photoactivated by 30 iterations (0.45 s) of irradiation with a 405-nm diode laser at 15% power.
Fluorescence images of activated mPAGFP in living cells were captured 0, 3, or 6 hours after photoactivation, and fluorescence intensities were determined using ImageJ ver. 1.41o (NIH). (Rigler et al., 1993; Kitamura et al., 2006) were performed on a ConfoCor 2 system and C-Apochromat 40×/1.2NA
Fluorescence correlation spectroscopy (FCS) analysis --FCS measurements
UV-VIS-IR Korr. water-immersion objective (Carl Zeiss). EGFP and EYFP were excited at 488 nm and 514 nm, respectively. Confocal pinhole diameter was adjusted to 70 µm at 488 nm or 74 µm at 514 nm.
Emission signals were detected with a 505 nm long-pass filter for EGFP or a 530-600 nm band-pass filter for EYFP. Cells were suspended in 0.2 ml PBS supplemented with 1% protease-inhibitor cocktail ) and the measured diffusion times of Rh6G under the condition (τ Rh6G ) and probe proteins (τ sample ), as follows:
For the diffusion coefficients, we applied the Stokes-Einstein equation,
Where the Boltzmann constant k, the viscosity of the solution η, and temperature T all remain constant throughout our studies. To yield a relationship between the diffusion coefficient and the Stokes' radius of the molecule, , we assumed that the molecule in question is a sphere with a Stokes' radius r H and a volume proportional to its molecular weight. Thus, we can relate the diffusion coefficient to molecular weight with . Count per molecule (CPM) was determined as mean brightness of measured sample was divided by the number of molecules determined by FCS analysis. CPM ratio was calculated as a CPM value of the sample in addition of MG-132 was divided by that in addition of DMSO as a control.
Poly-ubiquitination analysis -Supernatants of cell lysates were prepared in the same procedure as FCS analysis. The concentration of cell lysate was adjusted to 600 µg followed by determination of protein concentration using Bradford Ultra reagent (Novexin Ltd.). Supernatants of cell lysate supplemented with 1% TritonX-100 were incubated with rat monoclonal anti-GFP antibody-conjugated agarose beads (D153-8, MBL, Nagoya, Japan) for 1 h at 4 °C. After three times washing of the beads in PBS supplemented with 1% TritonX-100, precipitated proteins were solubilized in Laemmli sample buffer.
Protein samples were loaded in a 5-20% gradient gel (ePagel) and then transferred on Hybond-P PVDF membranes (GE healthcare) in a mini-transblot cell (BioRad). To detect Ubiquitin, SOD1-YFP, and GAPDH, rabbit polyclonal anti-Ubiquitin antibody (Z0458, Dako), mouse monoclonal anti-GFP antibody (GF200, Nacalai) and mouse monoclonal anti-GAPDH antibody (6C5, HyTest) were used respectively. After incubation with horse radish peroxidase-conjugated anti-immunoglobulin antibodies as a secondary antibody, membranes were treated in ECL plus reagent (GE Healthcare).
Chemiluminescent signals were detected in LAS4000 (Fujifilm, Tokyo, Japan).
FRET-FLIM analysis --Cells were fixed in 4% paraformaldehyde buffered with 100 mM HEPES-KOH (pH 7.5) for 30 min at 37 °C. After washing four times in TBS, cells were mounted in TBS, and FLIM measurements were performed using a combination of laser scanning microscopy and the time-correlated single photon counting (TCSPC) principle. A SP5 confocal laser-scanning unit (Leica, Wetzar, Germany) was connected to an inverted microscope DMI6000 (Leica). Sucrose density-gradient fractionation -Supernatants of cell lysates containing SOD1-G85R-YFP were prepared as for FCS measurements. Lysates were applied to 10-60% sucrose gradients containing 25 mM HEPES/KOH (pH 7.5). Gradients were centrifuged at 30,300 rpm for 16 hours in a SW41 swing rotor (Beckman Coulter, Indianapolis, IN) at 4 °C. Laemmli's sample buffer was added to each fraction, and the amount of SOD1-G85R-YFP was detected by SDS-PAGE followed by western blotting using anti-GFP antibody (GF200, Nacalai). 
Dead-cell analysis --
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